Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-28 @ 4:47 AM
Study NCT ID:
NCT05113368
Status:
RECRUITING
Last Update Posted:
2025-08-21
First Post:
2021-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Sponsor:
Sarah K. Lynam MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE2820
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |